Fortis Healthcare Q2 FY25 PAT up 5% at Rs. 193 Cr
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Hospital business revenues increase 13.9% to Rs. 1,655 crore
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Stable profits, low leverage to keep credit profiles comfortable
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
KIMS already have a multi-specialty hospital and gastro unit at Vizag
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Subscribe To Our Newsletter & Stay Updated